Core Insights - Conestoga Capital Advisors reported that equity markets reached new all-time highs in Q3 2025, but their Mid Cap Composite underperformed with a return of -3.2% net-of-fees compared to a 2.8% gain for the Russell Midcap Growth Index [1] - The focus on high-quality, profitable companies struggled in a risk-on environment during the quarter [1] Company Overview: IDEXX Laboratories, Inc. - IDEXX Laboratories, Inc. is a leader in diagnostics and information systems for veterinary, food, and water testing applications [3] - The company reported a one-month return of -1.74% and a 52-week gain of 38.06%, with shares closing at $637.13 on October 21, 2025, and a market capitalization of $50.97 billion [2] - IDEXX's revenue increased by 11% as reported and 9% organically in Q2 2025, despite weak veterinarian visits [4] Performance and Market Position - IDEXX Laboratories experienced strong earnings in Q3 2025, with accelerated organic revenue growth and rapid adoption of their latest premium instrument [3] - The number of hedge funds holding IDEXX shares decreased from 51 to 48 from the previous quarter, indicating a slight decline in popularity among institutional investors [4]

Core Insights - Crane NXT reported a sales growth of approximately 9% for the second quarter of 2025, with net sales reaching $404.4 million compared to $370.6 million in the same period of 2024 [4][5][7] - The company maintained its full-year earnings per share (EPS) guidance in the range of $4.00 to $4.30 [7][13] Financial Performance - The adjusted operating profit margin for the second quarter was approximately 21.2%, down from 24.1% in the previous year [6][10] - Operating profit decreased to $47.9 million, a decline of 29.1% from $67.6 million in the second quarter of 2024 [6][7] - The company experienced a core sales decline of 0.8%, primarily due to lower volumes in CPI [5][7] Segment Performance - Crane Payment Innovations segment reported net sales of $211.4 million, a decrease of 5.8% year-over-year, primarily driven by lower volumes [9] - Security and Authentication Technologies segment saw a significant increase in net sales to $193.0 million, up 32.0% year-over-year, largely due to acquisitions and core sales growth in international markets [10] Cash Flow and Financial Metrics - Cash provided by operating activities was $62.8 million, an increase from $56.8 million in the prior year [11] - The company held cash and cash equivalents of $152.5 million as of June 30, 2025, down from $165.8 million at the end of 2024 [12] Order Backlog - The total order backlog as of June 30, 2025, was $591.6 million, an increase from $547.8 million in the previous quarter [35]